Drawing for SEMA4

USPTO serial 86983080

SEMA4

Reviewed by CopyMark Law Group

Reg. 5330559Status 704Renewal
Filing date
Status date
Registration date
Nov 7, 2017
Examiner
FALK, JONATHAN ROBERT
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 704: Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active.

Need help with SEMA4?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*

Plus Government fees of $1,300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa C. Pavento

Lisa C. Pavento Meunier Carlin & Curfman LLC999 Peachtree Street NESuite 1300Atlanta, GA 30309

Goods and services

ClassDescriptionStatusFirst use
001[ Kits containing chemical and biochemical assays and reagents for scientific research use; nucleic acid and protein isolation kits comprised primarily of assays and reagents for use in epigenetic research and analysis; none of the aforementioned involve the use or study of semaphorins ]SECTION 8 - CANCELLEDMay 1, 2017
005[ Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, namely, cancer and Mendelian disorders; test kits consisting of medical diagnostic reagents and assays for testing in the field of the prevention and treatment of disorders and diseases; none of the aforementioned involve the use or study of semaphorins ]SECTION 8 - CANCELLEDMay 1, 2017
035[ Business consulting and business information services regarding precision health diagnosis and personalized treatment; business consulting and business information services regarding the analysis and packaging of health data; providing business information, namely, commercial corporate and statistical information provided on-line from a computer database or the Internet; statistical analysis and reporting services for business purposes; business consulting and business information services regarding the identification of drug targets; business consulting and business information services regarding bioinformatic analysis; population health management ]SECTION 8 - CANCELLEDMay 1, 2017
042[ Medical and scientific research in the field of biologic testing and interpretation, diagnosis, treatment, and health maintenance; bioinformatics interpretation of health data; medical and scientific research in the field of ancestry analysis for scientific research purposes; compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; analysis and screening of nucleic acids for scientific research purposes; genome mapping for scientific purposes; ] providing information in the field of disease classification for use in connection with diagnostic testing [; development of scientific research and technology for purposes of disease diagnosis, preventative health care, health monitoring, and personalized treatment; providing a website featuring non-downloadable software for patient access to health care services and health information; providing a website featuring non-downloadable software for patient access to diagnosis, treatment, and health maintenance information; providing a website featuring non-downloadable software for accessing, viewing, interacting with and downloading personal health records, diagnoses, treatment plans, and health monitoring information; scientific and medical research, namely, identifying drug targets; scientific research relating to population health management; none of the aforementioned involve the use or study of semaphorins ]ACTIVEMay 1, 2017
044Diagnostic services in the field of medicine; medical testing for diagnosis of diseases and treatment purposes [; bioinformatics analysis for medical diagnostic and personalized treatment purposes; biochemical testing for ancestry analysis and personalized diagnostics and treatments; nucleic acid analysis and screening for medical diagnostic and treatment purposes; DNA analysis and screening for medical diagnostic and treatment purposes; consulting services in the field of biological sequence and bioinformatic processing for medical diagnosis and treatment purposes; health care services, namely, leveraging health monitoring and data science to provide optimal health and disease prevention to patients; creating personalized preventative health-care programs and disease management programs; providing an online resource center featuring personalized health information based on health information and diagnostics; medical testing, namely, identifying drug targets for diagnostic or treatment purposes; none of the aforementioned involve the use or study of semaphorins ]ACTIVEMay 1, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 22, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 22, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 22, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 1, 2026WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Jun 1, 2026WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
May 1, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 1, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 30, 2025NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jan 30, 20258.PRREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED—
Jan 30, 2025PRANPOST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED—
Jan 30, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 28, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 28, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 28, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 28, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 28, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 28, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 7, 2024ES8RTEAS SECTION 8 RECEIVED—
Nov 8, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 7, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 10, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 10, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 10, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 4, 2021ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 7, 2018COC.CORRECTION UNDER SECTION 7 - PROCESSED—
May 7, 2018EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Dec 27, 2017PRAMPOST REGISTRATION ACTION MAILED - SEC. 7—
Dec 27, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 27, 2017FAXXFAX RECEIVED—
Nov 20, 2017ES7RTEAS SECTION 7 REQUEST RECEIVED—
Nov 7, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 30, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 29, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 13, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 13, 2017DPCCDIVISIONAL PROCESSING COMPLETE—
Sep 11, 2017IUAFUSE AMENDMENT FILED—
Sep 11, 2017DRRRDIVISIONAL REQUEST RECEIVED—
Sep 11, 2017ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Sep 11, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 30, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 17, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 15, 2017EX2GSOU EXTENSION 2 GRANTED—
Mar 15, 2017EXT2SOU EXTENSION 2 FILED—
Mar 15, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 30, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 29, 2016EX1GSOU EXTENSION 1 GRANTED—
Nov 28, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 20, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 20, 2016NREVNOTICE OF REVIVAL - E-MAILED—
Oct 20, 2016TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Oct 20, 2016PETGPETITION TO REVIVE-GRANTED—
Oct 20, 2016PROATEAS PETITION TO REVIVE RECEIVED—
Oct 17, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 17, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 15, 2016EXT1SOU EXTENSION 1 FILED—
Mar 15, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 19, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 19, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 30, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 15, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 10, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 8, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 8, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 16, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 16, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 11, 2015DOCKASSIGNED TO EXAMINER—
Jun 16, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Jun 15, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 15, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance